MG53 suppresses NF-κB activation to mitigate age-related heart failure

Area of Science:

• Biomedical Science
• Cardiovascular Research
• Aging Biology

Background:

• Aging is linked to chronic oxidative stress and inflammation, impairing tissue repair.
• MG53, a TRIM family protein, aids cell membrane repair in a redox-dependent way.
• MG53 expression decreases in aging and failing hearts, correlating with increased NF-κB activation.

Purpose of the Study:

• To assess the safety and efficacy of recombinant human MG53 (rhMG53) protein in aged mice.
• To investigate the therapeutic potential of rhMG53 for age-related cardiac dysfunction.

Main Methods:

• Longitudinal, systemic administration of rhMG53 protein in aged mice.
• Echocardiography and pressure-volume loop measurements to assess cardiac function.
• Biochemical and histological analyses to evaluate inflammation, apoptosis, and oxidative stress.

Main Results:

• rhMG53 treatment significantly improved cardiac function in aged mice.
• Cardioprotective effects were associated with suppressed NF-κB-mediated inflammation.
• rhMG53 administration reduced oxidative stress and apoptotic cell death in aged hearts.
• No adverse effects on major vital organ functions were observed with repetitive rhMG53 administration.

Conclusions:

• rhMG53 demonstrates therapeutic value in counteracting age-related cardiac decline.
• MG53's role in redox-dependent repair is crucial for maintaining cardiac health during aging.
• Targeting MG53 may offer a novel strategy for treating age-associated heart disease.